NTRP vs. MOND, YGMZ, BKNG, EXPE, XPO, MMYT, GATX, GXO, GBTG, and VRRM
Should you be buying Neurotrope stock or one of its competitors? The main competitors of Neurotrope include Mondee (MOND), MingZhu Logistics (YGMZ), Booking (BKNG), Expedia Group (EXPE), XPO (XPO), MakeMyTrip (MMYT), GATX (GATX), GXO Logistics (GXO), Global Business Travel Group (GBTG), and Verra Mobility (VRRM). These companies are all part of the "transportation services" industry.
Neurotrope vs.
Neurotrope (NASDAQ:NTRP) and Mondee (NASDAQ:MOND) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two companies based on the strength of their risk, community ranking, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.
Neurotrope has higher earnings, but lower revenue than Mondee.
In the previous week, Mondee had 4 more articles in the media than Neurotrope. MarketBeat recorded 4 mentions for Mondee and 0 mentions for Neurotrope. Mondee's average media sentiment score of 0.24 beat Neurotrope's score of 0.00 indicating that Mondee is being referred to more favorably in the news media.
Neurotrope has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500. Comparatively, Mondee has a beta of 0.27, indicating that its stock price is 73% less volatile than the S&P 500.
Neurotrope has a net margin of 0.00% compared to Mondee's net margin of -33.46%. Mondee's return on equity of 0.00% beat Neurotrope's return on equity.
Neurotrope received 165 more outperform votes than Mondee when rated by MarketBeat users. However, 83.33% of users gave Mondee an outperform vote while only 63.38% of users gave Neurotrope an outperform vote.
3.8% of Neurotrope shares are held by institutional investors. Comparatively, 32.1% of Mondee shares are held by institutional investors. 13.0% of Neurotrope shares are held by insiders. Comparatively, 46.1% of Mondee shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Mondee has a consensus price target of $3.83, suggesting a potential upside of 153,233.33%. Given Mondee's stronger consensus rating and higher possible upside, analysts clearly believe Mondee is more favorable than Neurotrope.
Summary
Mondee beats Neurotrope on 11 of the 15 factors compared between the two stocks.
Get Neurotrope News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Neurotrope Competitors List
Related Companies and Tools
This page (NASDAQ:NTRP) was last updated on 1/22/2025 by MarketBeat.com Staff
Free NTRP Stock Alerts